Cognitive-affective and somatic side effects of morphine and pentazocine: Side-effect profiles in healthy adults

Pain Medicine

Volumn 11, Issue 2, 2010, Pages 195-206

  Riley, Joseph L ^a   Hastie, Barbara A ^a   Glover, Toni L ^a   Fillingim, Roger B ^a,b   Staud, Roland ^c   Campbell, Claudia M ^d  

^a UNIVERSITY OF FLORIDA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Analgesia; Cluster analysis; Opioid; Pain; Pain sensitivity; Sex differences; Side effects

Indexed keywords

MORPHINE; PENTAZOCINE;

ADULT; ANALGESIC ACTIVITY; ANOREXIA; ARTICLE; BALANCE DISORDER; CLINICAL TRIAL; COGNITIVE AND AFFECTIVE SIDE EFFECTS QUESTIONNAIRE; COGNITIVE DEFECT; CONCENTRATION LOSS; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG CHOICE; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPHAGIA; DYSPNEA; EUPHORIA; FACTORIAL ANALYSIS; FATIGUE; FEMALE; FLUSHING; HEAT TOLERANCE; HUMAN; MALE; MEDICAL DECISION MAKING; MENTAL DISEASE; MOOD DISORDER; MUSCLE STIFFNESS; MUSCLE TWITCH; NAUSEA; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PARESTHESIA; PHYSICAL DISEASE; PREDICTIVE VALIDITY; QUESTIONNAIRE; RESTLESSNESS; SEDATION; SEX DIFFERENCE; SIDE EFFECT; SKIN TINGLING; SOMATIC SIDE EFFECTS QUESTIONNAIRE; SOMNOLENCE; STOMACH PAIN; SWEATING; THOUGHT DISORDER; TREMOR; VASODILATATION; VOMITING; XEROSTOMIA;

EID: 75249101896     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2009.00680.x     Document Type: Article

References (42)

1. Fillingim RB, Gear RW. Sex differences in opioid analgesia: Clinical and experimental findings. Eur J Pain 2004, 8:413-25.
2. Reisine T, Pasternak G, Hardman JG, Gilman AG, Limbird LE. Opioid analgesics and antagonists. Goodman and Gilman's the Pharmacological Basis of Therapeutics 1996, 521-55. In, eds., 9th, edition, New York, Pergamon Press
3. Portenoy RK. Management of common opioid side effects during long-term therapy of cancer pain. Ann Acad Med Singapore 1994, 23:160-70.
4. O'Mahony S, Coyle N, Payne R. Current management of opioid-related side effects. Oncology (Williston Park) 2001, 15(1):77-73.
5. Wheeler M, Oderda GM, Ashburn MA, Lipman AG. Adverse events associated with postoperative opioid analgesia: A systematic review. J Pain 2002, 3(3):159-80.
6. Zacny JP, Hill JL, Black ML, Sadeghi P. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther 1998, 286(3):1197-207.
7. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: Systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005, 7(5):R1046-51.
8. Cherny N, Ripamonti C, Pereira J. Working Group of the European Association of Palliative Care Network. Strategies to manage the adverse effects of oral morphine: An evidence-based report. J Clin Oncol 2001, 19(9):2542-54.
9. Sarton E, Olofsen E, Romberg R. Sex differences in morphine analgesia: An experimental study in healthy volunteers. Anesthesiology 2000, 93(5):1245-54.
10. Dahan A, Sarton E, Teppema L, Olievier C. Sex-related differences in the influence of morphine on ventilatory control in humans. Anesthesiology 1998, 88(4):903-13.
11. Zun LS, Downey LV, Gossman W, Rosenbaumdagger J, Sussman G. Gender differences in narcotic-induced emesis in the ED. Am J Emerg Med 2002, 20(3):151-4.
12. Cepeda MS, Farrar JT, Baumgarten M. Side effects of opioids during short-term administration: Effect of age, gender, and race. Clin Pharmacol Ther 2003, 74(2):102-12.
13. Fillingim RB, Ness TJ, Glover TL. Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 2004, 100(5):1263-70.
14. Fillingim RB, Ness TJ, Glover TL. Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesia. J Pain 2005, 6(2):116-24.
15. Gordon NC, Gear RW, Heller PH. Enhancement of morphine analgesia by the GABAB agonist baclofen. Neuroscience 1995, 69(2):345-9.
16. Gear RW, Gordon NC, Heller PH. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996, 205(3):207-9.
17. Fillingim RB, Hastie BA, Ness TJ. Sex-related psychological predictors of baseline pain perception and analgesic responses to pentazocine. Biol Psychol 2005b, 69(1):97-112.
18. Fillingim RB, Maixner W, Kincaid S, Silva S. Sex differences in temporal summation but not sensory-discriminative processing of thermal pain. Pain 1998, 75:121-7.
19. Maixner W, Gracely RH, Zuniga JR, Humphrey CB, Bloodworth GR. Cardiovascular and sensory responses to forearm ischemia and dynamic hand exercise. Am J Physiol 1990, 259:R1156-63.
20. Moore PA, Duncan GH, Scott DS, Gregg JM, Ghia JN. The submaximal effort tourniquet test: Its use in evaluating experimental and chronic pain. Pain 1979, 6:375-82.
21. Sternberg WF, Bailin D, Grant M, Gracely RH. Competition alters the perception of noxious stimuli in male and female athletes. Pain 1998, 76:231-8.
22. Davies PS, Roth-Roemer S, Coda B. Somatic side effects of morphine and hydromorphone during sustained equianalgesic infusions. Proc Am Pain Soc 1997, 16:120.
23. Roth-Roemer S, Coda B, Davies PS. Cognitive and psychomotor side effects of morphine and hydromorphone during sustained equianalgesic infusions. Proc Am Pain Soc 1997, 16:120.
24. Joreskog KG, Sorbom D. PRELIS 2 User's Reference Guide 1996, Chicago, IL, Scientific Software International
25. Joreskog KG, Sorbom D. LISREL 8: A Guide to the Program and Applications 1996, Chicago, IL, Scientific Software International
26. Hair JF, Anderson RE, Tatham RL, Black WC. Multivariate Data Analysis with Readings 1998, New York, MacMillan Publishing
27. Stadler M, Bardiau F, Seidel L, Albert A, Boogaerts JG. Difference in risk factors for postoperative nausea and vomiting. Anesthesiology 2003, 98(1):46-52.
28. Myles PS, Hunt JO, Moloney JT. Postoperative " minor" complications. Comparison between men and women. Anaesthesia 1997, 52(4):300-6.
29. Myles PS, McLeod AD, Hunt JO, Fletcher H. Sex differences in speed of emergence and quality of recovery after anaesthesia: Cohort study. BMJ 2001, 322(7288):710-1.
30. Zacny JP. Morphine responses in humans: A retrospective analysis of sex differences. Drug Alcohol Depend 2001, 63(1):23-8.
31. McNicol E, Horowicz-Mehler N, Fisk RA. Management of opioid side effects in cancer-related and chronic noncancer pain: A systematic review. J Pain 2003, 4(5):231-56.
32. Becerra L, Harter K, Gonzalez RG, Borsook D. Functional magnetic resonance imaging measures of the effects of morphine on central nervous system circuitry in opioid-naive healthy volunteers. Anesth Analg 2006, 103:208-16. table
33. Zubieta JK, Stohler CS. Neurobiological mechanisms of placebo responses. Ann N Y Acad Sci 2009, 1156:198-210.
34. Fields HL. Understanding how opioids contribute to reward and analgesia. Reg Anesth Pain Med 2007, 32:242-6.
35. Manner T, Kanto J, Scheinin H, Scheinin M. Meptazinol and pentazocine: Plasma catecholamines and other effects in healthy volunteers. Br J Clin Pharmacol 1987, 24(6):689-97.
36. Saarialho-Kere U, Mattila MJ, Seppala T. Parenteral pentazocine: Effects on psychomotor skills and respiration, and interactions with amitriptyline. Eur J Clin Pharmacol 1988, 35(5):483-9.
37. Sullivan MD, Edlund MJ, Zhang L, Unutzer J, Wells KB. Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 2006, 116:2087-93.
38. Sullivan MD, Edlund MJ, Steffick D, Unutzer J. Regular use of prescribed opioids: Association with common psychiatric disorders. Pain 2005, 119:95-103.
39. Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Opioid use behaviors, mental health and pain-Development of a typology of chronic pain patients. Drug Alcohol Depend 2009, May 25 [Epub ahead of print
40. Ives TJ, Chelminski PR, Hammett-Stabler CA. Predictors of opioid misuse in patients with chronic pain: A prospective cohort study. BMC Health Serv Res 2006, 6:46.
41. Lötsch J. Pharmacokinetic-pharmacodynamic modeling of opioids. J Pain Symptom Manage 2005, 29(5):S90-103. suppl
42. Chou R, Fanciullo GJ, Fine PG. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009, 10(2):113-30.